...
首页> 外文期刊>Critical reviews in oncology/hematology >Long non-coding RNA CASC2 in hunian cancer
【24h】

Long non-coding RNA CASC2 in hunian cancer

机译:long non-coding RNA CAS C2 in虎年cancer

获取原文
获取原文并翻译 | 示例
           

摘要

Long non-coding RNAs cover large part of the non-coding information of the human DNA, which represents more than 90% of the whole genome. They constitute a wide and complex group of molecules with more than 200 nucleotides, which generally lack an open reading frame, and are involved in various ways in the pathophysiology of cancer. Their roles in the regulation of gene expression, imprinting, transcription, and post-translational processing have been described in several types of cancer. CASC2 was discovered in 2004 in patients with endometrial carcinoma as a potential tumor suppressor. Since then, additional studies in other types of neoplasia have been carried out, and both mechanisms and interactions of CASC2 in cancer have been better elucidated. In this review, we summarize the current knowledge on the role of CASC2 in the genesis, progression, and clinical management of human cancer. (C) 2017 Elsevier B.V. All rights reserved.
机译:长期非编码RNA涵盖人DNA的非编码信息的大部分,其代表全基因组的90%以上。 它们构成具有超过200个核苷酸的宽且复杂的分子,通常缺乏开放的阅读框架,并且在癌症的病理生理学中涉及各种方式。 它们的作用在调节基因表达,印迹,转录和翻译后的若干类型的癌症中。 Casc2于2004年在患有子宫内膜癌作为潜在肿瘤抑制的患者中发现的。 从那时起,已经进行了其他类型的肿瘤的额外研究,并且癌症中Casc2的机制和相互作用已经更好地阐明。 在这篇综述中,我们总结了目前关于CASC2在人癌症的成因,进展和临床管理中的作用的知识。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号